199 related articles for article (PubMed ID: 24282525)
1. RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts.
Zhang X; Hagen J; Muniz VP; Smith T; Coombs GS; Eischen CM; Mackie DI; Roman DL; Van Rheeden R; Darbro B; Tompkins VS; Quelle DE
PLoS One; 2013; 8(11):e80228. PubMed ID: 24282525
[TBL] [Abstract][Full Text] [Related]
2. Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.
Adon AM; Zeng X; Harrison MK; Sannem S; Kiyokawa H; Kaldis P; Saavedra HI
Mol Cell Biol; 2010 Feb; 30(3):694-710. PubMed ID: 19933848
[TBL] [Abstract][Full Text] [Related]
3. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
5. RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner.
Hagen J; Muniz VP; Falls KC; Reed SM; Taghiyev AF; Quelle FW; Gourronc FA; Klingelhutz AJ; Major HJ; Askeland RW; Sherman SK; O'Dorisio TM; Bellizzi AM; Howe JR; Darbro BW; Quelle DE
Cancer Res; 2014 Nov; 74(22):6661-70. PubMed ID: 25273089
[TBL] [Abstract][Full Text] [Related]
6. RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.
Umesalma S; Kaemmer CA; Kohlmeyer JL; Letney B; Schab AM; Reilly JA; Sheehy RM; Hagen J; Tiwari N; Zhan F; Leidinger MR; O'Dorisio TM; Dillon J; Merrill RA; Meyerholz DK; Perl AL; Brown BJ; Braun TA; Scott AT; Ginader T; Taghiyev AF; Zamba GK; Howe JR; Strack S; Bellizzi AM; Narla G; Darbro BW; Quelle FW; Quelle DE
J Clin Invest; 2019 Mar; 129(4):1641-1653. PubMed ID: 30721156
[TBL] [Abstract][Full Text] [Related]
7. TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification.
Neo SH; Itahana Y; Alagu J; Kitagawa M; Guo AK; Lee SH; Tang K; Itahana K
Mol Cell Biol; 2015 Aug; 35(16):2851-63. PubMed ID: 26055329
[TBL] [Abstract][Full Text] [Related]
8. RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.
Kohlmeyer JL; Kaemmer CA; Umesalma S; Gourronc FA; Klingelhutz AJ; Quelle DE
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065204
[TBL] [Abstract][Full Text] [Related]
9. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
Cheng X; Shen Z; Yang J; Lu SH; Cui Y
J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
[TBL] [Abstract][Full Text] [Related]
10. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.
Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K
Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559
[TBL] [Abstract][Full Text] [Related]
11. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
Chen D; Shan J; Zhu WG; Qin J; Gu W
Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
[TBL] [Abstract][Full Text] [Related]
12. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
[TBL] [Abstract][Full Text] [Related]
13. The Myc-nucleophosmin-ARF network: a complex web unveiled.
Li Z; Hann SR
Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
[TBL] [Abstract][Full Text] [Related]
14. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
15. p53 dependent centrosome clustering prevents multipolar mitosis in tetraploid cells.
Yi Q; Zhao X; Huang Y; Ma T; Zhang Y; Hou H; Cooke HJ; Yang DQ; Wu M; Shi Q
PLoS One; 2011; 6(11):e27304. PubMed ID: 22076149
[TBL] [Abstract][Full Text] [Related]
16. Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model.
Liang Y; Gao H; Lin SY; Goss JA; Du C; Li K
Oncogene; 2015 Aug; 34(33):4368-78. PubMed ID: 25362854
[TBL] [Abstract][Full Text] [Related]
17. Abnormal centrosome amplification in the absence of p53.
Fukasawa K; Choi T; Kuriyama R; Rulong S; Vande Woude GF
Science; 1996 Mar; 271(5256):1744-7. PubMed ID: 8596939
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1.
Oikawa T; Okuda M; Ma Z; Goorha R; Tsujimoto H; Inokuma H; Fukasawa K
Mol Cell Biol; 2005 May; 25(10):4046-61. PubMed ID: 15870277
[TBL] [Abstract][Full Text] [Related]
19. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts.
Iovino F; Lentini L; Amato A; Di Leonardo A
Mol Cancer; 2006 Sep; 5():38. PubMed ID: 16987420
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
Shinmura K; Bennett RA; Tarapore P; Fukasawa K
Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
